19 September 2019


Winner: ETC-159, PORCN (“Porcupine”) protein inhibitor for colorectal cancer and other solid tumours
Presented by: F. Joel Leong, M.D., Ph.D., Chief Development Officer, A*STAR, Experimental Drug Discovery Centre

Runner-up: RNA trans-splicing-based suicide gene therapy targeting hepatocellular carcinoma
Presented by: Volker Patzel, Ph.D., Assistant Professor, National University of Singapore, Yong Loo Lin School of Medicine